Hodgkin Lymphoma Presenting as Hemophagocytic Lymphohistiocytosis: A Case Report and Review of Published Cases [PDF]
Introduction: Hemophagocytic lymphohistiocytosis (HLH) is a serious syndrome that occurs in associationwith malignancy, infections and autoimmune diseases.Case presentation: A 30 years old female patient presented with fever, splenomegaly, pancytopenia ...
Somaia Mousa
doaj +1 more source
Use of Rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas [PDF]
The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of ...
Fozza, Claudio+1 more
core +4 more sources
Purpose Hodgkin Reed-Sternberg cells harbor alterations in chromosome 9p24.1, leading to overexpression of programmed death-ligand 1 (PD-L1) and PD-L2. Pembrolizumab, a programmed death 1-blocking antibody, demonstrated a high overall response rate (ORR)
Robert Chen+16 more
semanticscholar +1 more source
Primary Non-Hodgkin Lymphoma of The Cervix [PDF]
Background: There are only a few reports that exist regarding primary non-Hodgkin lymphoma of the genital tract. In this article, one case of primary B-cell type non-Hodgkin lymphoma (NHL) of the cervix is presented.
Haleh Ayatollahi+2 more
doaj +2 more sources
Complete remission of Hodgkin Lymphoma after a concurrent infection with COVID-19: systematic review and meta-analysis [PDF]
Through December 2019, novel coronavirus (SARS-CoV-2) pneumonia (COVID-19) was reported in Wuhan and has since rapidly spread throughout China.
Nasser ghaly yousif
doaj +1 more source
Hodgkin lymphoma: A review and update on recent progress
Hodgkin lymphoma (HL) is a unique hematopoietic neoplasm characterized by cancerous Reed‐Sternberg cells in an inflammatory background. Patients are commonly diagnosed with HL in their 20s and 30s, and they present with supradiaphragmatic lymphadenopathy,
S. Shanbhag, R. Ambinder
semanticscholar +1 more source
Purpose B-cell leukemia/lymphoma-2 (BCL-2) overexpression is common in many non-Hodgkin lymphoma (NHL) subtypes. A phase I trial in patients with NHL was conducted to determine safety, pharmacokinetics, and efficacy of venetoclax, a selective, potent ...
M. Davids+20 more
semanticscholar +1 more source
Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study [PDF]
BACKGROUND: Targeting signaling pathways is an attractive approach in many malignancies. The PI3K/Akt/mTOR pathway is activated in a number of human neoplasms, accompanied by lower overall and/or disease free survival.
A Akcakanat+52 more
core +1 more source
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma : endpoints of a spectrum of one disease? [PDF]
In contrast to the commonly indolent clinical behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical stages and has a poor prognosis ...
Döring, Claudia+13 more
core +3 more sources
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member ...
R. Hoppe+34 more
semanticscholar +1 more source